Organigram Global (OGI) Goodwill (2018 - 2026)

Organigram Global (OGI) posted quarterly Goodwill of $38.3 million for Q1 2026, up 1.69% quarter-over-quarter from $37.7 million in Q4 2025.

Organigram Global (OGI) Goodwill (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Goodwill for 4 consecutive years, with $38.3 million the latest figure, recorded in Q1 2026.

In Q1 2026, Goodwill changed N/A year-over-year to $38.3 million; the TTM figure through Mar 2026 stood at $38.3 million (changed N/A YoY), while the FY2025 annual figure was $37.7 million, changed N/A from the prior year.
Goodwill advanced to $38.3 million in Q1 2026 per OGI's latest filing, from $37.7 million in the prior quarter.
Across five years, Goodwill topped out at $38.3 million in Q1 2026 and bottomed at $10.1 million in Q3 2022.
Historically, Goodwill has averaged $31.1 million across 3 years, with a median of $37.9 million in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-
10	Organigram Global	150.66 Mn	150.54 Mn	28.97 Mn

Download Data